Human properdin deficiency is an X-linked disorder strongly predisposing to meningococcal disease which has been recorded in over 50 cases ofvarious ethnic origins. Immunochemically, total deficiency (type I), partial deficiency (type II), and deficiency due to a dysfunctional molecule (type III) can be differentiated. It is therefore most likely that the causative molecular defects will show considerable genetic heterogeneity. Analysis of the properdin locus at Xpl1.3-Xp11.23 has led to the characterization of two polymorphic (dC-dA).* (dG-dT).
case/fatality rate. While the exact mechanisms for the predominance of Gram-negative infections in the properdin-deficient individuals and the apparent absence of infectious complications in some of the affected remain to be elucidated, the more than 50 cases described to date demonstrate the need for diagnostic techniques to allow prenatal and carrier detection (2, 3) . Three different types of properdin deficiency have been described on the basis of immunochemical and functional analyses (2) . Type I is characterized by protein levels below the detection limit ofstandard immunochemical methods (RIA or ELISA) and undetectable properdin function. In type II properdin serum levels are reduced to levels between -1 and 10% of normal (4, 5) , the inclusion of partial deficiency cases with concentrations between 20 and 35% of normal in this category remains questionable as X-linked transmission has not been clearly demonstrated (6, 7) . Finally, in type III properdin deficiency normal amounts of properdin are antigenically detectable but the protein appears functionally defective (8) . This phenotypic heterogeneity together with the variable ethnic and geographic origin of the patients suggest that the disorder is most likely genetically heterogeneous with different mutations present in the various pedigrees.
Recently the cloning and sequencing ofthe human properdin locus at Xpl 1.3-Xpl 1.23 has led to the characterization of a dinucleotide repeat containing sequence < 15 kb downstream of the properdin structural gene (9, 10) . This region encompasses two perfect (dC-dA)n. (dG-dT)n repeats interrupted by 83 bp. Here we report the use of haplotyping of these two microsatellite markers for the carrier detection of properdin deficiency.
Methods
Subjects. A total of 27 individuals from three families (Tunisian Sephardic family 1, Scottish Caucasoid families 2 and 3) including 7 properdin-deficient individuals, 4 obligate carriers, and 5 potential carriers were studied on the DNA level (Fig. 1) . Families 1 and 2 have been reported previously ( 11, 12 (13). The following sandwich enzyme-linked immunosorbent assay was used to measure the concentration of properdin in plasma and serum samples: wells were coated with the IgG fraction of a polyclonal rabbit anti-human properdin antiserum prepared and purified using standard techniques (150,ul of 1/2,000 dilution of 15 mg/ml solution); samples (150 Ml) of plasma, serum, or purified properdin were added and incubated at 37°C for 2 h; the bound properdin was detected by the addition of the biotinylated IgG fraction from rabbit anti-human properdin (150 Al of 1/2,000 dilution of 10 mg/ml solution), streptavidinalkaline phosphatase (150 Ml of 1 / 10,000 dilution) and phosphatase substrate (50 Al of 1 mg/ml solution ofp-nitrophenyl disodium phosphate). The plates were monitored at 405 nm after 15 min. All dilutions were made in Tris-buffered saline pH 7.4 containing 0.5 mg/ml BSA. The assay was sensitive down to a level of 1 ng/ml of human properdin.
Microsatellite typing. DNA of properdin-deficient individuals, their families, and the control population were prepared either as fluid phase DNA according to standard protocols or as agarose-embedded Figure 2 . Electrophoresis of doublestranded polymerase chain reaction products on a nondenaturing polyacrylamide gel and subsequent photochemical silver staining. Amplification across dinucleotide repeats typically produces a multi-banded pattern consisting of a major band and additional "shadow" bands migrating slower, i.e., as a cathodal minor band, and faster, i.e., as an anodal minor 4 band. The molecular basis for this phenomenon is not fully understood: strand slippage or staggered pairing of partially extended products during early cycles are possible explanations. To assist in allele identification major band levels are marked by arrowheads on both panels. The an earlier suggestion the size of the most frequent allele was taken as the reference point (the zero level) and the other alleles designated in relation to this zero level ( 15) . In the present sample, eight alleles have been identified for repeat 1 and five alleles have been identified for repeat 2. Alleles at both loci can be combined in a haplotype thus yielding a highly informative marker system. In 119 X-chromosomes of Centre d'Etude du Polymorphisme Humaine (CEPH)' parents 14 haplotypes were observed and 5 of these occurred at a frequency 5% or higher (Table I) . Haplotype heterozygosity in 39 CEPH family mothers was > 87%. 1 . Abbreviation used in this paper: CEPH, Centre d'Etude du Polymorphisme Humaine.
Immunochemical investigations. The serum properdin concentrations of the members of the three families were measured, and showed phenotypic heterogeneity with respect to properdin deficiency. While in the deficient individuals offamily 2 (1-1, 1-3, 1-5 , and 11-6) the properdin concentration was below the detection limit of the immunosorbent assay of 1 ng/ ml the deficient individuals of family 3 (11-1 and 11-2) had -0.5% of the normal serum properdin concentration (-_ 10 ,ug/ml (16)) in an ELISA (Table II) . The AP50 values for plasma samples from the index case and his brother, in family 3, were < 2% ofnormal levels. Reconstituting these two plasma samples to the normal level with purified human properdin raised the AP50 values to the normal range. The AP50 values for plasma samples from the father, the mother (an obligate carrier of the deficiency allele), and the daughter, in family 3 were very similar to each other and within the normal AP50 titration range. Probable and definite carriers frequently show properdin levels and AP50 activities within the normal range. It is therefore apparent that immunochemical and functional assays do not allow the reliable differentiation between obligate and possible carriers in properdin deficiency.
Haplotyping in the properdin-deficient families. The power of the haplotype approach is demonstrated by the observed heterozygosity in all female family members in the sample. There was complete correspondence between the functional and immunological identification of deficient individuals (Table II). The silent allele was found linked to the 0 2 haplotype in families 1 and 2 and to the 0 0 haplotype in family 3.
therefore become increasingly popular for linkage and allelic association studies. In the case ofproperdin deficiency the availability oftwo polymorphic microsatellites closely linked to the structural locus allowed to establish microsatellite haplotypes thereby further enhancing the power ofsimple sequence repeat analyses. The combination of the polymerase chain reaction with a nonisotopic detection method makes the described diagnostic procedure immediately applicable in routine laboratones.
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Discussion
Immunochemical and functional investigations of the properdin levels in families with cases of properdin deficiency do not allow the unambiguous identification of carriers or a prenatal diagnosis of the condition ( 17) . In all three families with properdin deficiency haplotyping for microsatellites closely linked to the properdin gene on the X chromosome allowed identification of the defective allele through two generations. Recombinatorial events were not observed and are, given the size of the properdin gene and the close proximity ofthe dinucleotide repeats, extremely unlikely. However, although the degree of heterozygosity in females for the microsatellite haplotypes described is very high compared to conventional restriction fragment length polymorphism markers and the average single microsatellite homozygosity in carriers is possible and could necessitate typing for additional flanking markers, such as the polymorphic DXS228 microsatellites (10) .
Interestingly, the mutation leading to the type II deficiency in family 3 has occurred in the context of the haplotype most frequently found in 116 parental CEPH chromosomes, whereas the third most frequent haplotype carried a type II deficiency mutation in family 1 and a type I deficiency mutation in family 2. This may indicate an increased mutability of the properdin locus characterized by the 0 2 haplotype but more importantly it supports the concept of independent mutational events in the three pedigrees studied and quite possibly in most of the properdin deficiencies described. Considering the phenotypic spectrum ofproperdin deficiency incuding dysfunctional variants (8) and various degrees of partial defects (4-7) the underlying molecular defects can be expected to be quite diverse. Such genetic heterogeneity has been directly demonstrated for C3 deficiency, which is also found in more than one ethnic background ( 18, 19 
